News Articles

Health 13 Nov 2024

Avita brings RECELL back to Australia

The revolutionary spray-on skin treatment developed in Perth by burns surgeon Fiona Wood is being reintroduced to the Australian market by Avita Medical.

Health 31 May 2024

Avita secures US approval

Avita Medical shares have had a moderate rise after a US regulator approved the next reiteration of a regenerative cell system for burns developed by Perth surgeon Fiona Wood.

Technology, Innovation & Science 08 Jun 2023

Avita gains key US approval

The medtech company jointly established by Perth burns surgeon Fiona Wood has achieved a landmark regulatory approval in the US for its spray-on skin technology.

Bulls N' Bears 20 Sep 2022

From lab to boardroom – kick-starting medtech brainwaves

Helping patients by solving an unmet medical need whilst creating jobs and generating a revenue stream might seem like the ultimate win-win-win for a healthcare professional. However, getting a good idea to market means embarking on a long and winding road to commercialisation. Enter the Australian Clinical Entrepreneur Program launched recently in Perth.

Appointments 20 Jul 2018

Board Moves July 20, 2018

Avita Medical has expanded its management team in the commercial, legal and medical affairs functions to support the planned US launch of the RECELL® Autologous Cell Harvesting Device in the treatm

Deals 06 Jun 2018

Avita raises $16m

Avita Medical has tapped investors for $16 million as the company prepares to launch its spray-on burns treatment, which was co-developed by medical entrepreneur Fiona Wood.

Education 28 Nov 2017

Entrepreneurialism needed within an evolving system

Funding is the biggest issue within the healthcare sector and is the one thing that keeps burns surgeon Fiona Wood awake at night, attendees at a Business News Success & Leadership breakfast heard this morning.

Deals 11 Oct 2017

Avita taps investors for $17m

The company commercialising an innovative spray-on burns treatment co-developed by medical entrepreneur Fiona Wood has launched a $17 million capital raising.

Education 28 Sep 2017

Avita seeks US market pre-approval

Health technology company Avita Medical has submitted a pre-market approval application to the US Food and Drug Administration for its ReCell regenerative medicine technology.

Contracts 21 Sep 2017

Avita signs $30m contract expansion

Health technology company Avita Medical has signed a $US24.3 million ($A30.5 million) expansion to its contract with a US government research agency, for further funding of its ReCell device trials.

Appointments 02 Jun 2017

Board Moves June 2, 2017

Greg Gilbert has resigned as non-executive director of BPH Energy.

Technology, Innovation & Science 29 Sep 2016

Avita Medical sets sights on Iran

Perth-based Avita Medical has struck a distribution deal in Iran for its spray on skin products for the treatment of burns, wounds and skin defects, potentially paving the way for a new market for the the group.

Appointments 01 Jul 2016

Board moves June 11-29

Auroch Minerals announced that Dr. Andrew Tunks has committed to a full-time role as Auroch CEO.

Education 27 Jun 2016

Avita wins $11m contract extension

Spray-on skin technology provider Avita Medical has won a contract extension aimed at helping a US biomedical research organisation prepare for treating burns from a nuclear explosion.

Deals 16 Jun 2016

Avita Medical in $11m raising

Perth-based Avita Medical has announced plans to raise up to $11.4 million to fund the company's expansion into the US market.

Education 07 Jun 2016

Avita Medical expands in Asia

Perth-based Avita Medical has expanded its Asian market, signing a deal to have its products distributed in Malaysia.

Technology, Innovation & Science 09 Mar 2016

Avita, Nuheara in Techboard ranking

Local companies Avita Medical, Nuheara and ResApp Health have all featured in this fortnight's Techboard list, which ranks the online presence of Perth tech firms.

Deals 05 Feb 2016

Avita sells respiratory business

Perth-based regenerative medicine company Avita Medical says it will be able to focus more on its core ReCell technology after completing the sale of its respiratory business for $2.47 million.

Education 13 Jan 2016

Wood retires from Avita board

Avita Medical founder Fiona Wood has stepped down from the company's board as the regenerative medicine developer drives towards the US market.

Deals 20 Oct 2015

Avita raises $10m for ReCell rollout

Regenerative medicine company Avita Medical has raised $10 million from investors to support the commercialisation of its ReCell device, which is being trialled by a US government agency.

Deals 30 Sep 2015

Avita Medical wins $24m US contract

Fiona Wood-founded Avita Medical has received a $US16.9 million ($A24.1 million) commitment from a US government agency to fund a trial of its ReCell device.

Deals 12 Mar 2015

Avita shares slide on $5m placement

Shares in technology company Avita Medical tumbled today on news it had closed a heavily discounted placement to raise $5 million.

Mining 18 Nov 2014

TFS promotes Gooding to chairman

TFS Corporation non-executive director Dalton Gooding has been promoted to the role of non-executive chairman after joining the company just one month ago, after Patrick O'Connor stood down from the role at a board meeting this morning.

13 Nov 2014

Avita falls on UK delay

Shares in Avita Medical have hit a 2014 low following the company's announcement efforts to commercialise in the UK have hit a snag.

Mining 16 Oct 2014

TFS appoints Gooding to board

Sandalwood producer TFS Corporation has appointed Gooding Partners founder Dalton Gooding as an independent non-executive director, effective immediately.

16 Sep 2014

Avita announces major trial changes

Perth biotechnology firm Avita Medical has announced major changes to a clinical trial in the US it hopes will improve shareholder confidence.

05 Sep 2014

Biotechs bleed cash in search for profit

WA biotechs are drowning in a sea of red as yet more negative results are reported.

20 May 2014

Avita Medical reveals new chairman

Biotech company Avita Medical has appointed a new chairman after shareholder outrage against the company's remuneration report last year claimed the scalp of former chairman Dalton Gooding.

11 Dec 2013

Dolphin steps down as Avita CEO

William Dolphin has agreed to step down as chief executive of biotech company Avita Medical, and Dalton Gooding has resigned after announcing his intention to do so at the company's annual general meeting in November.

Special Reports 05 Dec 2013

Investors cut CEOs some slack

FEATURE: It has been a difficult year for many of WA's listed entities, but investors are backing the performance of most of the state's top executives.

Special Reports 28 Nov 2013

Biotech sector haunted by 'valley of death'

FEATURE: The state's biotechnology sector is heating up as investors look for the next wave of investment opportunities amid waning resources investment.

Technology, Innovation & Science 22 Nov 2013

Gooding to step down after huge ‘no’ vote

Dalton Gooding has agreed to stand down as chairman of biotech company Avita Medical but shareholders today supported the re-elect

Deals 05 Sep 2012

Avita announces $10m capital raising plan

Medical research firm Avita Medical has announced a proposal to raise up to $10 million, with Octa Phillip Bioscience Managers committing to tip in $3 million.

08 Dec 2009

Avita steady after FDA approves trial

Shares in Avita Medical were unchanged today despite receiving approval from the US Food and Drug Administration (FDA) to begin clinical trials of its ReCell Spray-On Skin device early next year, after the company suspended initial trials in 2008.

20 Jul 2009

Avita secures $5m facility for ReCell

Avita Medical has secured a $5 million funding facility from Melbourne-based Fortrend Securities for its skin injury device as part of a strategy to accelerate sales in Europe.

Financial Services 02 Apr 2009

Avita Medical jumps on 72% sales lift

Shares in Avita Medical have jumped after sales for its asthma products jumped 72 per cent to nearly $2 million.

Financial Services 29 Aug 2008

Avita Medical reduces net loss in FY08

Lower operating expenses have reduced Avita Medical Ltd's full year net loss to $12.2 million, down from the previous year's loss of $15 million.

07 Aug 2008

Avita signs Greek distribution deal

Perth-based Avita Medical Ltd, formerly Clinical Cell Culture, has signed a distribution agreement with Greek company D.Analytica Ltd to supply its Funhaler spacer to the country's pharmacies and healthcare providers.

16 Jul 2008

Avita records 16% revenue increase

Perth-based Avita Medical Ltd, formerly Clinical Cell Culture, has posted a 16 per cent increase in unaudited revenue over the 2008 financial year, underpinned by strong growth sales of its respiratory products.

Financial Services 26 Jun 2008

C3 officially changes name to Avita

Perth-based burns treatment developer Clinical Cell Culture has today begun trading on the stock market under its new name, Avita Medical Ltd.

News Articles for Avita Medical

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark